Skip Navigation


European Heart Journal Advance Access originally published online on February 16, 2005
European Heart Journal 2005 26(7):740-741; doi:10.1093/eurheartj/ehi157
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
26/7/740    most recent
ehi157v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Komócsi, A.
Right arrow Articles by Horváth, I. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Komócsi, A.
Right arrow Articles by Horváth, I. G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oupjournals.org

 

Raising the loading dose of clopidogrel: aiming at the proper target?

András Komócsi

Heart Institute, Medical Faculty, University of Pécs, H-7624 Pécs, 13 Ifjúság u., Hungary, Tel: +36 72 536 001/5660, Fax: +36 72 536 387, E-mail address: andras.komocsi@aok.pte.hu

Tünde Pintér

Heart Institute, Medical Faculty, University of Pécs, H-7624 Pécs, 13 Ifjúság u., Hungary

Iván G. Horváth

Heart Institute, Medical Faculty, University of Pécs, H-7624 Pécs, 13 Ifjúság u., Hungary

The first 10% of the full text of this article appears below.

With great interest, we read the excellent article of Angiolillo et al.1 which attempted to characterize the effect of 600 mg loading dose (LD) clopidogrel in patients undergoing coronary stenting (CS). Supplementation of aspirin with thienopyridines resulted in reduction of acute–subacute thrombotic . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?